result in a disproportionately high density ofMHC class I protein/peptide complex on the cell surface. Soluble peptide could then potentially generate a stronger T cell response than is usually observed for class I-restricted antigens . We show here that peptide fragments can effectively generate a strong primary in vitro CTL response. This response is both peptide specific and MHC restricted but clearly differs from the secondary CTL response seen after conventional in vivo immunization with live virus.
Materials and Methods
Mice. C57BL/6, B10.A(4R), and B10.A(5R) mice were obtained from the Scripps Clinic and Research Foundation vivarium .
Monoclonal Antibodies . mAbs used in this study were 13 .4 (antiThy-1.2, reference 17), RL .172 .4 (anti-CD4 (L3T4), reference 18), and 3.168 (anti-CD8 (Lyt-2), reference 19) . These were used with rabbit complement to deplete the appropriate effector cell populations immediately before addition to cytotoxicity assays .
Antigens. OVA (Grade VI ; Sigma Chemical Co ., St . Louis, MO) was used in native form or after cleavage with trypsin (T OVA)' or cyanogen bromide (CN OVA) . For T OVA, 100-250 mg of OVA was reduced in 0 .2 M 2-ME/8 M urea overnight and then alkylated with 0.25 M iodoacetic acid for 2 h. The alkylated protein was exhaustively dialyzed and then cleaved with 1% trypsin in 50 mM NH4CO4, pH 8.0, overnight. For CN OVA, 250 mg of OVA was reacted overnight with 500 mg of CN dissolved in 70% formic acid . The solvent was evaporated under a stream of nitrogen and the residue was suspended in water and lyophilized . No intact OVA remained in the CN OVA and T OVA preparations, as assessed by SDS gel electrophoresis. The synthetic peptide antigens NP36s-380 (IASNENMET MESSTLE) and OVAIII-122 (YPILPEYLQCVK) were synthesized on an automated peptide synthesizer (Applied Biosystems, Inc., Foster City, CA) and their purity was assessed by HPLC and amino acid analysis .
Influenza Virus Strains. Influenza virus stocks of A/PR/8 and A/HK/68 were obtained from A. Vitiello, Scripps Clinic and Research Foundation . Virus was grown in the allantoic sacs of 11-d-old embryonated chicken eggs and stored as infectious allantoic fluid at -70°C .
Target Cells for Cytotoxicity Assays. The tumor cell lines used were the la-lines, EL4 (C57BL/6, H-2b thymoma), P815 (DBA/2, H-2a mastocytoma), CBA-Dl (CBA, H-2k lymphoma), and R1 .E (TL-) (C58/J, H-2k thymoma) . The R1 .E(TL -) line also fails to express class I MHC gene products on the surface due to a defect in (32-microglobulin expression (20) . EL4 was transfected with OVA cDNA in a plasmid construct with the human 0-actin promoter to derive the OVA-producing cell line E.G7-OVA, which will be described in detail elsewhere (Moore, M. W., M. J. Bevan, and R R. Carbone, manuscript in preparation) . Peritoneal exudate cells for use as targets were induced by injecting 1 .5 ml of 3 01o wt/vol thioglycolate (Difco Laboratories Inc., Detroit, MI) intraperitoneally 4 d before harvesting .
Primary Peptide-speck Cytotoxic Effector Ibpulations. Unless otherwise stated, 60 x 106 spleen cells from unprimed 6-8-wk-old C57BL/6 mice were incubated for 5 d in 10 ml of RP10 (RPMI-1640 with 10% FCS and 50 gM 2-ME) in upright 25-cm' flasks at 37°C in 7olo C02/air. Concentrations of peptides added to the cultures were 100 wg/ml for CN OVA and T OVA or 5 jig/ml for NP36s-3ao.
Long-Term CTL Lines. Primary cytotoxic effector populations were harvested after 7 d, and 5 x 10 6 recovered cells were restimulated with 20 x 10 6 irradiated (3,000 rod) syngeneic spleen cells in 10 ml of RP10 at the same peptide concentrations as the primary cultures . Subsequent weekly restimulations were carried out with 2-4 x 10 6 responder cells and 20 x 106 irradiated syngeneic spleen cells in 10 ml of RP10 with 5% supernatant from Con A-stimulated rat spleen cells and 50 mM a-methyl mannoside in upright 25-cm2 flasks . Peptides were used at the same concentrations as in primary cultures.
' Abbreviations used in this paper: CN OVA, cyanogen bromide-cleaved ovalbumin; T OVA, trypsinized ovalbumin.
CNOVA-speck CTL Clones . Responder cells recovered from long-term CN OVA-specific populations were cloned at 10, 3, 1, and 0.3 cells/well in 96-well plates (No. 3596 ; Costar, Cambridge, MA) . Irradiated syngeneic spleen cells (5 x 105 cells/well) and CN OVA (100 gg/ml) in medium containing 5% supernatant from Con A-stimulated rat spleen cells were used for cloning . Cells from wells with positive signs of growth (from 3 and 1 cell/well plates) were expanded and tested for CN OVA-specific lysis. Clones were maintained by weekly restimulation of 1-2 x 10 5 cells with 5 x 106 irradiated syngeneic cells in 2 ml of CN OVA containing medium in 24-well plates (No. 3484 ; Costar) .
Generation of Anti-influenza A/PR/8 CTL . In vitro secondary anti-A/PR/8 effectors were derived using responder spleen cells from C57BL/6 mice immunized 4 wk earlier with 100 HAU of A/PR/8 influenza virus intravenously. Stimulator cells were prepared by infecting 10 8 irradiated (3,000 rad) C57BL/6 cells with 0 . cells from unimmunized C57BL/6 mice with 100 pg/ml CN OVA generated effectors that efficiently lysed the syngeneic tumor target EL4 in the presence of CN OVA (Fig . 1 a) . These effector cells caused only a low level of specific target cell lysis in the presence of T OVA, and no significant enhancement of killing was seen in the presence of native OVA when compared with EL4 targets alone (Fig . 1 a) . Fig. 1 b shows that effectors of reciprocal specificity resulted when T OVA was used as the in vitro immunogen . A 5-d incubation of spleen cells with native OVA (Fig . 1 c) failed to generate effectors capable of lysing targets in the presence of T OVA, CN OVA, or native OVA.
Synthetic peptides can substitute for endogenously synthesized viral proteins during CTL recognition (7) (8) (9) . We attempted to raise CTL by primary in vitro stimulation using one such peptide, NP365-380, which corresponds to the fragment between residues 365 and 380 from the influenza virus A/PR/8 nucleoprotein (21) . Fig. 1 d shows that incubating spleen cells from unprimed C57BL/6 mice with NP365-380 generated effectors capable of lysing EL4 targets only in the presence of this synthetic peptide and eliminated the possibility that the primary in vitro antipeptide activity was due to an artifact peculiar to the OVA protein .
Effect of Cell Density on the Primary Response. During the course of our studies we The resulting effectors were then tested for lysis of "Cr-labeled EL4 target cells in the presence of (0100 Pg/ml CN OVA, (0100 wg/ml T OVA, (")100 ug/ml native OVA, (*)10 wg/ml NP365-380, or (O) medium alone.
noticed that the most critical parameter affecting the primary in vitro response was the starting cell density, as demonstrated for CN OVA in Fig. 2 . In this experiment, starting cell numbers in the range of 40-80 x 106 cells/flask resulted in the stimulation of a strong CN OVA-specific activity, with 20 x 106 cells/flask giving much weaker activity. Such weak stimulation was generally observed for most attempts at priming using < 40 x 10 6 cells/flask . Cell numbers of -60 x 10 6 were routinely used for our experiments. All three peptide preparations were capable of priming at this density, with CN OVA giving the best response, followed by T OVA and then NP365-380 Antipeptide Cytotoxic Effector Cells are Thy-I + and CD8+ Cells. Peptide-specific lines were established by repeated antigen stimulation of effectors generated from the primary in vitro cultures . To determine whether peptide-specific recognition was indeed due to T cell activity, these lines were treated with antiThy-1, anti-CD8 or anti-CD4 antibodies, and/or complement immediately before their addition to assay cultures . Fig. 3 shows that depletion of CD8+ or Thy-1+ cells from both anti-CN OVA and anti-NP365-380 lines abrogated all specific lytic activity. Neither complement alone nor anti-CD4 had any effect . Similarly, all the T OVA activity is sensitive to antiThy-1 and anti-CD8 antibody and complement treatment (data not shown) . Effectors were therefore classical CD8+ T cells.
OVA111-122 Is a Target Peptidefor Anti-T OVA CTL. Based on the preliminary analysis of a chromatographic separation of an OVA tryptic digest (not shown), a limited Effector / Target Ratio number of peptides were synthesized in an attempt to identify the fragments recognized by the OVA digest-specific CTL. Anti -T OVA CTL lines showed strong lysis of the H-2-compatible target EL4 in the presence of one such peptide, synthetic tryptic fragment OVAn1-122 (Table I ) . This peptide did not sensitize targets to the same extent as the whole T OVA digest, suggesting that OVA111-122 represented a major but not exclusive determinant for the bulk of antiT OVA CTL. In other experiments we estimated that the activity against this peptide accounted for 10-100 % of the total CTL activity. Peptide-speck Lysis Is Class I Restricted. Thioglycolate-induced peritoneal exudate cells from C57L/6 (Kb, Db ), B10.A(4R) (K k , Db ), and B10.A(5R) (Kb, Dd) mice served as convenient targets for mapping the restriction element used by the three different effector populations. 3 . Peptide-specific effectors are CD8' T cells . Long-term (a) anti-CN OVA and (b) anti-NP365-380-specific effector populations were treated with complement in the presence of (/) anti Thy-1, ( " ) anti-CD4, (O) anti-CD8, or (EI) no antibody before addition to 51 Cr-labeled EL4 in the presence of (a) 100 ug/ml CN OVA or (b) 10pg/ml NP365-380 . population derived from primary in vitro stimulation . $ 100 jig/ml T OVA digest . 3 10 Vg/ml OVAtit-122 C57BL/6 and B10.A(4R) but not B10.A(5R) cells in the presence of NP365-380. Recognition of the NP365-380 peptide was clearly restricted to the Db locus . This coincides with the fact that NP365-380 CTL derived from virus-infected C57BL/6 mice are also Db restricted (7, 22) . The anti -T OVA CTL response was also predominantly Db restricted since strong peptide-specific killing was observed for both C57BL/6 and B10 .A(4R) targets (Table II) . In this case, weak lysis was apparent for B10.A(5R) targets in the presence of the T OVA digest, suggesting a minor Kb_ restricted activity.
Anti-CN OVA CTL efficiently recognized all three peritoneal exudate targets in the presence of CN OVA (Table 11 ). In addition, this line also lysed the class II-negative tumor targets P815 (H-2 d ) and CBA-Dl(H-2 k ) in a peptide-specific manner (Fig .  4 a) . The C58/J (H-2 k)-derived line R1 .E (TL-) is R2 -microglobulin-negative, and accordingly, does not express class I MHC gene products on its surface. The failure of anti-CN OVA CTL to lyse R1 .E (TL-) (Fig . 4 a) suggests that anti-CN OVA CTL are indeed class I restricted despite an unusual crossreaction on at least three different H-2 haplotypes . No peptide-specific lysis of tumor targets other than the class II-negative EL4 was observed for anti -T OVA CTL (Fig . 4 b) and anti-NP365-380 (data not shown), confirming that these activities show classical class I MHC restriction .
Individual CN OVA-specific Clones Recognize Peptide in the Context of H-2°, H-2d, and
H-2k. The broad MHC haplotype crossreactivity shown by the anti-CN OVA population may have been a consequence of a more limited recognition by individual T cell clones ofdifferent specificities within the whole population . For example, there may be some clones that recognize CN OVA in association with H-26 and H-2' but not H-2 d, while others are restricted to H-2b and H-2d . This possibility was ruled out by examing the anti-CN OVA response at the clonal level. Five CN OVA-specific clones were established by limiting dilution from the bulk population used in the preceding section. All five clones exhibited CN OVA-specific lysis on each of the three tumor targets (Table III) CN OVA4  37  24  40  22  47  34  50  41  52  40  None  4  3  3  2  3  0  8  6  15  10   P815  CN OVA  42  30  59  36  68  52  55  57  66  50  None  4  1  6  0  4  0  17  11  28  8   CBA-D1  CN OVA  46  38  78  56  66  57  58  57  62  55  None  2  -1  14  3  5  4  9  7 Fa0~-were tested for killing on 51Cr CN OVA digest on restricting elements encoded by the H-2 b, H-2d, and H-2' haplotypes.
We have not determined whether the peptide is the same for all five clones nor have we identified the peptide(s) responsible for target sensitization able to select a population of CTL capable of lysing A/PR/8-infected EL4 cells from the OVA digest-specific CTL lines.
Discussion
The major finding of our work is that peptides can elicit strong, MHC-restricted CTL responses measurable after 5 d of culture with spleen cells from unprimed mice . Conventional presentation of MHC-restricted antigens, such as by virus-infected or minor histocompatibility-disparate cells, does not result in measurable primary in vitro responses. This was evident by the failure of influenza A/PR/8-infected cells to induce a primary response (Fig . 6 d) . Previously, only MHC-different stimulators (25) (26) (27) or hapten-modified syngeneic cells (28, 29) have been reported to give vigorous primary responses. The antipeptide responses reported here are much weaker than alloreactive responses and are very dependent on a high cell density in the cultures. However, it is clear that while influenza virus-infected cells cannot stimulate the response, one antigeneic peptide from the NP component of the virus can. Similarly, we would predict that while it is not possible to observe a primary in vitro CTL response of H-2b female spleen cells to the male-specific-H Y antigen by stimulation with male cells, if we knew the sequence of one of the H-Y antigenic peptides we would be able to use such a peptide to generate a response .
To explain the success of exogenous peptide immunization and the failure of endogenous peptide presentation in vitro, we invoke the determinant density argument . It has been argued previously that the strong response to MHC allogeneic cells is due to the high density of MHC determinants (15, 16) . It is possible that an analogous situation pertains as a consequence of the exogenous addition of peptides at high concentrations . Under these circumstances it may be that a large fraction of MHC molecules are occupied by the added peptide, while in the case of endogenous protein synthesis the analogous peptide would occupy a much smaller fraction of the MHC molecules. With a higher surface density of a particular peptide/MHC complex we would expect T cells with lower receptor affinity to be able to respond. Thus, the bulk of antipeptide CTL may be unable to lyse cells expressing endogenous determinants . This is exactly what was observed for anti-NP365-380 CTL; the majority ofeffectors failed to lyse A/PR/8-infected targets (Fig. 5 c) . Within this population there existed a small proportion of CTL with high receptor affinity, and these were selectively expanded by stimulating with the A/PR/8-infected spleen cells (Fig. 6 b) .
In contrast to the anti-NP365-380 CTL, no corresponding E.G7-OVA-reactive CTL were detected within the anti-CN OVA or anti-T OVA populations. We attribute this to differences between the OVA peptides and the NP365-380 peptide related to antigen processing . The nucleoprotein peptide mimics the endogenous CTL determinant derived by the cellular degradation of the A/PR/8 nucleoprotein. It is possible that the OVA peptides used for in vitro priming, such as OVA111-122, are not produced as a consequence of cellular processing of the OVA gene product. Consistent with this suggestion, CTL derived by direct stimulation with OVAI1I-122-containing digest would then fail to lyse E.G7-OVA since it does not express the appropriate determinant (Fig. 5 b) . Furthermore, we have observed that in vivo immunization with E .G7-OVA elicits OVA-specific CTL that fail to lyse targets in the presence of OVAIll-122 (Moore, M. W., M. J. Bevan, and E R. Carbone, manuscript in preparation) .
It is likely that our success in eliciting a class I-restricted CTL response is due in part to the direct association of degraded antigen with the MHC products . This may have obviated the need for any form of cellular processing . Antigen processing combined with intracellular trafficking are thought to be the essential mechanisms that discriminate between class I-and class II-restricted antigen presentation (10, 11) . The two processing pathways are thought to be distinct . Native, exogenous proteins are endocytosed and degraded within the endosomal compartment before reexpression on the cell surface in association with class II MHC molecules (30, 31) . In contrast, endogenous class I-restricted antigens are thought to be degraded by an alternative mechanism (32, 33) . Thus, native OVA, which must be degraded for antigen presentation, failed to elicit primary effectors in vitro and was incapable of sensitizing targets for lysis by peptide-specific CTL. Recently, Staerz et al. (34) have disputed the suggestion that class I and class II antigen presentation represent separate pathways . They have claimed that native protein can elicit peptide-specific, class I-restricted CTL by in vivo priming. We suggest that many of their results may be explained on the basis of direct in vitro peptide stimulation rather than successful in vivo immunization with native protein.
There may be other features that distinguish endogenous and exogenous peptide presentation in addition to the differences in processing requirements and cell surface densities discussed above. For example, the broad MHC haplotype crossreactivity noted for the in vitro-induced anti-CN OVA CTL (Fig . 4 a) may represent a unique association of peptide with class I protein at sites that are not accessible to endogenous peptide determinants . Such sites may exist at monomorphic regions of the K-, D-, or L-encoded proteins or on the proteins encoded by the relatively conserved Qa/Tla genes. However, despite all these differences, it is clear that exogenous peptides can effectively substitute for conventional CTL determinants, such as viral antigens, both for target sensitization (7, 9) and for CTL priming, as demonstrated here for NP365-380 . The ability to elicit CTL by peptide stimulation affords us a relatively simple technique with which to study class I-restricted T cell recognition. Since T cells are specific for denatured rather than native forms of foreign antigens, peptides clearly represent a potential means of effective vaccination . In the particular case of influenza, specific CTL populations (35) and clones (36, 37) have proven effective in protecting naive individuals against lethal influenza infection. It may be of interest to ascertain whether the virus-reactive CTL derived from in vitro peptide priming can also provide the same protection in vivo . If that is the case, then primary in vitro CTL stimulation could provide us with information that will prove useful in the design of efficient antiviral vaccines .
Summary
Antigen-specific cytotoxic T cells can be generated by primary in vitro stimulation of spleen cells from C57BL/6 mice with appropriate peptide fragments. This response can be elicited without prior in vivo immunization . Chicken OVA fragmented with either cyanogen bromide (CN OVA) or trypsin (T OVA) was used as a source of mixed peptides . A synthetic peptide, NP365-380, representing the sequence 365-380 from influenza virus A/PR/8 nucleoprotein, was also used, since this contains the main determinants recognized by CTL generated from H -2 b mice infected with A/PR/8 virus. The primary in vitro cytotoxic T cell response was peptide specific, since targets were lysed only in the presence of appropriate peptide antigens . Native OVA could not elicit primary effectors in vitro nor could it sensitize targets for lysis by OVA digest-specific CTL. A synthetic peptide corresponding to residues 111-122 within the OVA sequence could sensitize targets for lysis by effectors induced against T OVA.
Effectors generated by in vitro stimulation were CD8+ , CD4-, and H-2Db-restricted for NP365-38o and T OVA recognition . CN OVA-specific effectors were also CD8`, CD4-, but surprisingly, were able to lyse a range of H-2-different targets in an antigen-specific manner. These effectors failed to lyse a tumor line that does not express class I MHC molecules. This broad MHC restriction pattern was also apparent at the clonal level.
In all cases, the antipeptide CTL generated by primary in vitro stimulation were inefficient in lysing target cells expressing endogenous forms of antigens, such as influenza virus-infected cells or cells transfected with the OVA cDNA . However, cytotoxic T cell lines generated in vitro against the NP365-380 peptide did contain a minor population of virus-reactive cells that could be selectively expanded by stimulation with A/PR/8-infected spleen cells. These results are discussed in terms of class I-restricted T cell stimulation in the absence of antigen processing by high surface densities of peptide/MHC complexes .
